- Report
- September 2023
- 120 Pages
Global
From €5671EUR$5,950USD£4,787GBP
- Report
- May 2024
- 135 Pages
Global
From €6195EUR$6,499USD£5,229GBP
- Report
- June 2024
- 200 Pages
Global
From €7578EUR$7,950USD£6,396GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1906EUR$2,000USD£1,609GBP
- Report
- May 2024
- 137 Pages
Global
From €6195EUR$6,499USD£5,229GBP
- Drug Pipelines
- July 2024
- 60 Pages
Global
From €1430EUR$1,500USD£1,207GBP
- Report
- June 2024
- 200 Pages
Global
From €7578EUR$7,950USD£6,396GBP
- Report
- April 2024
- 185 Pages
Global
From €4671EUR$4,900USD£3,942GBP
- Report
- January 2024
- 175 Pages
Global
From €4766EUR$5,000USD£4,023GBP
- Report
- February 2024
- 120 Pages
Asia Pacific
From €4718EUR$4,950USD£3,983GBP
- Report
- March 2018
- 179 Pages
Global
From €1311EUR$1,375USD£1,106GBP
€2621EUR$2,750USD£2,213GBP
- Report
- January 2022
- 60 Pages
Global
From €3765EUR$3,950USD£3,178GBP
- Report
- January 2022
- 60 Pages
Global
From €3765EUR$3,950USD£3,178GBP
- Report
- August 2022
United States
From €1849EUR$1,940USD£1,561GBP
- Report
- August 2022
Global
From €753EUR$790USD£636GBP
- Report
- August 2021
Global
From €3803EUR$3,990USD£3,210GBP
- Report
- August 2021
Europe
From €3260EUR$3,420USD£2,752GBP
- Report
- February 2021
Global
From €2821EUR$2,960USD£2,382GBP
- Clinical Trials
- January 2020
- 318 Pages
Global
From €2383EUR$2,500USD£2,011GBP
- Report
- August 2022
- 376 Pages
Global
From €2383EUR$2,500USD£2,011GBP
![Loading Indicator](//www.researchandmarkets.com/images/loading.gif)
The Urinary Incontinence Drug market is a subset of the Urological Disorders Drugs market, which includes drugs used to treat a variety of conditions related to the urinary system. Urinary Incontinence Drugs are used to treat the involuntary leakage of urine, which can be caused by a variety of conditions, including overactive bladder, stress incontinence, and urge incontinence. These drugs can be administered orally, topically, or through injections. Commonly used drugs include anticholinergics, beta-3 agonists, and alpha-blockers.
Some of the companies in the Urinary Incontinence Drug market include Allergan, Astellas Pharma, Pfizer, Merck, and Sanofi. Show Less Read more